Literature DB >> 1337998

Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.

C Parker1, G V Sherbet.   

Abstract

MTS1 is a metastasis-associated gene highly expressed in highly metastatic tumours. NM23 has been described as a putative metastasis suppressor gene. Here we show that thapsigargin (which raises intracellular calcium [Ca2+]i from intracellular stores) and verapamil (which blocks Ca2+ influx) both down-regulate MTS1 and NM23 gene expression in the poorly metastatic F1 and highly metastatic ML8 variants of the B16 murine melanoma without altering their metastatic behaviour. The data presented here suggest that Ca2+ released from intracellular stores could be functionally differentiated from influxed Ca2+ and could be activating different components of the Ca2+ signalling system. Many of the cellular responses to calcium are mediated through calmodulin. We have therefore further investigated the role of Ca2+ in the regulation of the MTS1 and NM23 genes using the calmodulin inhibitor W-7. Both these genes were down-regulated after treatment of the F1 and ML8 cell variants. We have shown previously that retinoic acid reduces lung colonization by the highly metastatic variant ML8 and that melanocyte stimulating hormone (MSH) enhances lung colonization by the poorly metastatic variant F1, with corresponding changes in the relative expression of NM23 and MTS1. Here we have found that verapamil and thapsigargin have no effect on lung colonization, possibly due to both genes being down-regulated. These data support the concept that NM23 and MTS1 gene expression is linked and that metastatic potential may be determined by their relative expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337998     DOI: 10.1097/00008390-199212000-00007

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma.

Authors:  Samudra K Dissanayake; Ashani T Weeraratna
Journal:  Methods Mol Biol       Date:  2008

2.  The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Authors:  Samudra K Dissanayake; Michael Wade; Carrie E Johnson; Michael P O'Connell; Poloko D Leotlela; Amanda D French; Kavita V Shah; Kyle J Hewitt; Devin T Rosenthal; Fred E Indig; Yuan Jiang; Brian J Nickoloff; Dennis D Taub; Jeffrey M Trent; Randall T Moon; Michael Bittner; Ashani T Weeraratna
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

Review 3.  Collagen induced MMP-2 activation in human breast cancer.

Authors:  E W Thompson; M Yu; J Bueno; L Jin; S N Maiti; F L Palao-Marco; H Pulyaeva; J W Tamborlane; R Tirgari; I Wapnir
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Expression of NM23 in human melanoma progression and metastasis.

Authors:  D J Easty; K Maung; I Lascu; M Véron; M E Fallowfield; I R Hart; D C Bennett
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

5.  The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion.

Authors:  Tao Li; Li Yi; Long Hai; Haiwen Ma; Zhennan Tao; Chen Zhang; Iruni Roshanie Abeysekera; Kai Zhao; Yihan Yang; Wei Wang; Bo Liu; Shengping Yu; Luqing Tong; Peidong Liu; Meng Zhu; Bingcheng Ren; Yu Lin; Kai Zhang; Cheng Cheng; Yubao Huang; Xuejun Yang
Journal:  Cell Death Dis       Date:  2018-02-20       Impact factor: 8.469

Review 6.  The Role of Calmodulin in Tumor Cell Migration, Invasiveness, and Metastasis.

Authors:  Antonio Villalobo; Martin W Berchtold
Journal:  Int J Mol Sci       Date:  2020-01-24       Impact factor: 5.923

7.  S100A4 released from highly bone-metastatic breast cancer cells plays a critical role in osteolysis.

Authors:  Haemin Kim; Bongjun Kim; Sang Il Kim; Hyung Joon Kim; Brian Y Ryu; Junho Chung; Zang Hee Lee; Hong-Hee Kim
Journal:  Bone Res       Date:  2019-09-23       Impact factor: 13.567

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.